Q: What is Sprycel used for?

Sprycel is used to treat chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia .

Q: How does Sprycel work?

Mechanism of Action Sprycel belongs to a class of medications called kinase inhibitors. It is designed to target and block the action of certain abnormal proteins that signal cancer cells to multiply uncontrollably. Targeting Abnormal Proteins In many cases of chronic myeloid leukemia (CML), a genetic change creates an abnormal protein called BCR-ABL. This protein acts like a switch that is stuck in the "on" position, constantly signaling the body to produce too many white blood cells. Sprycel works by: Binding to the BCR-ABL protein to block its signaling activity. Inhibiting other proteins, such as SRC family kinases, which are also involved in the growth of cancer cells. Slowing Cancer Growth By interfering with these specific signals, Sprycel helps to slow down or stop the production of cancerous cells. This targeted approach focuses on the molecular drivers of the disease, helping to manage the overproduction of abnormal blood cells in the body.

Q: What are the active ingredients in Sprycel?

The active ingredient in Sprycel is dasatinib .

Q: What are the side effects of Sprycel?

Common side effects of Sprycel may include: diarrhea fatigue headache and others Always consult with a healthcare professional about potential side effects.

Q: What drug class is Sprycel?

Sprycel belongs to the tyrosine kinase inhibitor drug class.

Q: What is the dosage of Sprycel and how do I take it?

How to Take Sprycel Sprycel is taken by mouth, typically once a day, although some treatment plans may require it to be taken twice daily. It can be taken with or without food. To help you remember, try to take it at the same time every day. The tablets should be swallowed whole. Do not crush, chew, or break the tablets. If you have trouble swallowing the tablets, talk to your healthcare provider about alternative options. Handling and Safety This medication can be absorbed through the skin and may be harmful to an unborn baby. People who are pregnant or planning to become pregnant should not handle the tablets. Caregivers should use disposable gloves when handling the medication or wash their hands thoroughly with soap and water immediately after contact. Missed Dose If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take extra medicine or two doses at the same time to make up for a missed dose.

Q: Is Sprycel safe during pregnancy and breastfeeding?

Pregnancy Considerations Sprycel can cause harm to a developing fetus. Research indicates that the medication may lead to birth defects or other toxic effects on an embryo. Individuals who are pregnant or considering pregnancy should talk to their doctor about the risks associated with this medication. To prevent pregnancy during treatment, the following precautions are generally advised: For females: Use effective contraception during treatment and for 30 days after the last dose. For males: Use effective contraception during treatment and for 30 days after the last dose if your partner can become pregnant. Breastfeeding Considerations It is currently unknown if the active ingredient in Sprycel passes into human breast milk. Because of the potential for serious adverse reactions in a nursing child, breastfeeding is not recommended while taking this medication. It is advised to wait at least 2 weeks after the final dose before breastfeeding.

Q: What forms and strengths does Sprycel come in?

Available Forms Sprycel is provided in two formulations for oral administration: Oral Tablets: These are film-coated tablets that are intended to be swallowed whole. They should not be crushed, chewed, or broken. Powder for Oral Suspension: This formulation is designed to be mixed with water to create a liquid suspension before use.

Q: What is the FDA approval status of Sprycel?

FDA Approval History Sprycel was first approved by the U.S. Food and Drug Administration (FDA) in June 2006. Since its initial approval, its use has been expanded to include both adult and pediatric patients for various stages of leukemia. Approved Indications The FDA has approved Sprycel for the treatment of: Newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase. Ph+ CML in chronic, accelerated, or myeloid/lymphoid blast phase in patients who are resistant or intolerant to other therapies, including imatinib. Ph+ acute lymphoblastic leukemia (ALL) in patients with resistance or intolerance to prior therapy. Pediatric patients (1 year and older) with Ph+ CML in chronic phase or newly diagnosed Ph+ ALL in combination with chemotherapy. Safety and Regulatory Monitoring While Sprycel does not currently have a boxed warning or a Risk Evaluation and Mitigation Strategy (REMS) program, the FDA has issued safety communications regarding its use. In 2011, the FDA notified the public that Sprycel may increase the risk of pulmonary arterial hypertension (PAH), a condition involving high blood pressure in the arteries of the lungs. Healthcare providers are advised to evaluate patients for signs and symptoms of PAH before and during treatment.

Question 1

What is Sprycel?

Accepted Answer

Sprycel is a kinase inhibitor that works by interfering with the growth of cancer cells. It targets and blocks the action of an abnormal protein that signals these cells to multiply, which helps slow or stop the progression of the disease.

By targeting specific proteins involved in cell signaling, this medication helps manage the overproduction of cells associated with certain conditions. This targeted approach is intended to help control the spread of the disease.

Question 2

What is Sprycel used for?

Accepted Answer

Sprycel is used to treat chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.

Question 3

How does Sprycel work?

Accepted Answer

Mechanism of Action

Sprycel belongs to a class of medications called kinase inhibitors. It is designed to target and block the action of certain abnormal proteins that signal cancer cells to multiply uncontrollably.

Targeting Abnormal Proteins

In many cases of chronic myeloid leukemia (CML), a genetic change creates an abnormal protein called BCR-ABL. This protein acts like a switch that is stuck in the "on" position, constantly signaling the body to produce too many white blood cells. Sprycel works by:

Binding to the BCR-ABL protein to block its signaling activity.
Inhibiting other proteins, such as SRC family kinases, which are also involved in the growth of cancer cells.

Slowing Cancer Growth

By interfering with these specific signals, Sprycel helps to slow down or stop the production of cancerous cells. This targeted approach focuses on the molecular drivers of the disease, helping to manage the overproduction of abnormal blood cells in the body.

Question 4

What are the active ingredients in Sprycel?

Accepted Answer

The active ingredient in Sprycel is dasatinib.

Question 5

What are the side effects of Sprycel?

Accepted Answer

Common side effects of Sprycel may include:

diarrhea
fatigue
headache
and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Sprycel?

Accepted Answer

Sprycel belongs to the tyrosine kinase inhibitor drug class.

Question 7

What is the dosage of Sprycel and how do I take it?

Accepted Answer

How to Take Sprycel

Sprycel is taken by mouth, typically once a day, although some treatment plans may require it to be taken twice daily. It can be taken with or without food. To help you remember, try to take it at the same time every day.

The tablets should be swallowed whole. Do not crush, chew, or break the tablets. If you have trouble swallowing the tablets, talk to your healthcare provider about alternative options.

Handling and Safety

This medication can be absorbed through the skin and may be harmful to an unborn baby. People who are pregnant or planning to become pregnant should not handle the tablets. Caregivers should use disposable gloves when handling the medication or wash their hands thoroughly with soap and water immediately after contact.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take extra medicine or two doses at the same time to make up for a missed dose.

Question 8

Is Sprycel safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy Considerations

Sprycel can cause harm to a developing fetus. Research indicates that the medication may lead to birth defects or other toxic effects on an embryo. Individuals who are pregnant or considering pregnancy should talk to their doctor about the risks associated with this medication.

To prevent pregnancy during treatment, the following precautions are generally advised:

For females: Use effective contraception during treatment and for 30 days after the last dose.
For males: Use effective contraception during treatment and for 30 days after the last dose if your partner can become pregnant.

Breastfeeding Considerations

It is currently unknown if the active ingredient in Sprycel passes into human breast milk. Because of the potential for serious adverse reactions in a nursing child, breastfeeding is not recommended while taking this medication. It is advised to wait at least 2 weeks after the final dose before breastfeeding.

Question 9

What forms and strengths does Sprycel come in?

Accepted Answer

Available Forms

Sprycel is provided in two formulations for oral administration:

Oral Tablets: These are film-coated tablets that are intended to be swallowed whole. They should not be crushed, chewed, or broken.
Powder for Oral Suspension: This formulation is designed to be mixed with water to create a liquid suspension before use.

Question 10

What is the FDA approval status of Sprycel?

Accepted Answer

FDA Approval History

Sprycel was first approved by the U.S. Food and Drug Administration (FDA) in June 2006. Since its initial approval, its use has been expanded to include both adult and pediatric patients for various stages of leukemia.

Approved Indications

The FDA has approved Sprycel for the treatment of:

Newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase.
Ph+ CML in chronic, accelerated, or myeloid/lymphoid blast phase in patients who are resistant or intolerant to other therapies, including imatinib.
Ph+ acute lymphoblastic leukemia (ALL) in patients with resistance or intolerance to prior therapy.
Pediatric patients (1 year and older) with Ph+ CML in chronic phase or newly diagnosed Ph+ ALL in combination with chemotherapy.

Safety and Regulatory Monitoring

While Sprycel does not currently have a boxed warning or a Risk Evaluation and Mitigation Strategy (REMS) program, the FDA has issued safety communications regarding its use. In 2011, the FDA notified the public that Sprycel may increase the risk of pulmonary arterial hypertension (PAH), a condition involving high blood pressure in the arteries of the lungs. Healthcare providers are advised to evaluate patients for signs and symptoms of PAH before and during treatment.

Question 11

What should I know about Sprycel and cost?

Accepted Answer

Insurance and Pharmacy Factors

The out-of-pocket cost for Sprycel is largely determined by your insurance plan's formulary and benefit design. Most plans cover the medication, but the amount you pay, such as a copay or coinsurance, can vary. Additionally, Sprycel is typically handled by specialty pharmacies rather than standard retail locations, which can affect how the drug is billed and delivered.

Generic Dasatinib

Generic versions of dasatinib are available. These versions contain the same active ingredient as Sprycel but are usually offered at a lower price point. Availability may depend on your specific pharmacy and insurance requirements.

Financial Assistance Programs

Financial support may be available for eligible patients through various channels:

Manufacturer Coupons: Patients with commercial insurance may qualify for co-pay assistance programs that lower monthly costs.
Patient Assistance Programs: These programs, often run by the manufacturer or non-profit organizations, provide medication at low or no cost to patients who meet specific income and insurance criteria.

Sprycel

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Sprycel

Hospitals.net Disclosure